The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients. - Abstract - Europe PMC
The ITP Support Association - Clinical Trials
Recent advances in the pathogenesis and treatment... | F1000Research
Paroxysmal Nocturnal Hemoglobinuria Clinical Trials
Algorithm of the clinical management of paroxysmal nocturnal... | Download Scientific Diagram
Eculizumab decreases the procoagulant activity of extracellular vesicles in paroxysmal nocturnal hemoglobinuria: A pilot prospective longitudinal clinical study - Thrombosis Research
Frontiers | Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT | Immunology
References in Eculizumab for paroxysmal nocturnal haemoglobinuria - The Lancet
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2022
Paroxysmal nocturnal hemoglobinuria revisited: news on pathophysiology, clinical course and treatment
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria - ScienceDirect
A novel patient-reported outcome instrument assessing the symptoms of paroxysmal nocturnal hemoglobinuria, the PNH-SQ | Journal of Patient-Reported Outcomes | Full Text
Current Opinions on the Clinical Utility of Ravulizumab for the Treatm | TCRM
JCM | Free Full-Text | Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties | HTML
Frontiers | Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT | Immunology
The prothrombotic state in paroxysmal nocturnal hemoglobinuria: a multifaceted source | Haematologica
Paroxysmal Nocturnal Haemoglobinuria Complicated by Budd–Chiari Syndrome: A Case Study – Consult QD
JCM | Free Full-Text | Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties | HTML
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial - The Lancet Haematology
![PDF] Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8f7a7aa2a9a68213076775dcdb459ca5e4347a58/5-Figure3-1.png "PDF] Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy. | Semantic Scholar")
PDF] Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy. | Semantic Scholar
Ultomiris Efficacy | PNH Treatment and Symptoms | Ultomiris.com
Paroxysmal nocturnal hemoglobinuria: Recommendations for diagnostic testing | British Columbia Medical Journal
Biomedicines | Free Full-Text | The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies | HTML
Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review - Devalet - 2015 - European Journal of Haematology - Wiley Online Library
